Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
RESTASIS® (cyclosporine ophthalmic emulsion) 0.05%
Medication labelWhy this: Advisory · dailymed-prescription
RESTASIS ® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.
- generic_name
- cyclosporine
- product_names
- cyclosporine
- ndc
- 54868-4793, 0023-9163, 54868-4793-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en